Abstract
BioSense was created in 2003 with the intent of establishing an integrated system of nationwide public health surveillance for the early detection of potential bioterrorism-related syndromes or other public health emergencies. BioSense has evolved into the National Syndromic Surveillance Program that includes the BioSense Platform - an improved suite of analytical tools based in a cloud environment. To address the user community's priorities of the platform's current system requirements and the preference for including other software on the platform to improve syndromic surveillance data processing, CDC conducted a pilot project to evaluate the tools, SAS and ESSENCE.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
